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Purpose: Chronic kidney disease (CKD) induces frailty and worsens quality of life (QOL), even in the early stages of
the disease and in young patients. However, there is a lack of knowledge about the relationship between frailty
and QOL in CKD patients. Thus, we investigated this relationship in a sample of CKD patients.
Methods: A cross-observational study was conducted, in which 61 CKD patients receiving pre-dialysis treatment
were assessed. All participants completed the Short Form-36 Health Survey (SF-36). We used valid and reliable
methods to classify subjects as frail or non-frail according to Johansen’s et al. (2007) criteria. A one-way analysis of
variance (ANOVA) and chi-square tests were used to compare the groups. In addition, Spearman’s correlation
analysis was conducted to measure associations between identified variables and frailty. We also performed simple
linear regression using the SF-36 physical and mental composite scores.
Results: Almost half of the sample (42.6%) exhibited evidence of frailty. The groups differed significantly in terms of
age, gender, and all SF-36 domains, excluding Social Functioning and Role Emotional. Frailty was significantly
associated with all SF-36 domains, again excluding Social Functioning and Role Emotional. Regression analysis
revealed no significant between-group differences in composite physical and mental health scores generated by
the SF-36 (p > 0.05).
Conclusion: Frail and non-frail CKD patients differed significantly in seven of the eight SF-36 domains. The frail
group displayed diminished physical and mental functioning when their SF-36 scores were divided by their physical
and mental composite scores. Frailty was correlated with QOL domains, with the exception of the social domain.
There is a need for interventions targeting the characteristics of frailty, to provide better treatment and optimize
overall QOL.
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Introdução: É conhecido que a doença renal crônica implica em pior qualidade de vida e em fragilidade, mesmo
em fases iniciais da doença e em sujeitos mais jovens. Existe uma lacuna no conhecimento relacionando fragilidade
e qualidade de vida em pacientes com doença renal crônica (DRC), em especial nos pacientes em pré-diálise.
Objetivo: Investigar a qualidade de vida, a fragilidade e as possíveis relações entre elas, em uma população com
DRC.
Métodos: Estudo observacional e transversal com 61 pacientes com DRC entre os estágios 3 a 5 em fase
pré-dialítica. Os participantes responderam à escala do questionário SF-36, que se caracteriza por uma versão reduzida
do questionário da Medical Outcomes Study, traduzida e validada para o português. Para avaliação da fragilidade,
utilizamos a proposta de Johansen et al. (2007), sendo os sujeitos classificados em frágeis e não frágeis. A comparação
entre os grupos foi realizada por ANOVA one-way com análise post hoc de Tukey e pelo teste de qui-quadrado,
conforme o tipo de variável analisada. Além disso, foi realizada a correlação de Pearson ou Spearman para medir a
associação entre variáveis identificadas e a fragilidade. Realizamos, também, uma regressão linear simples, ajustada para
sexo e idade pelos escores físico e mental do SF-36.
Resultados: A média de idade foi 60,5 ± 11,5 anos. Do total de pacientes, 42,6% apresentavam fragilidade. Os grupos
foram diferentes entre si quanto à idade, ao sexo e todos os domínios do SF-36, exceto nos aspectos sociais e nos
aspectos emocionais. Quando correlacionamos a fragilidade com as variáveis do estudo, encontramos forte associação
com todos os domínios da qualidade de vida, exceto nos aspectos sociais e nos aspectos emocionais. Através da análise
de regressão ajustada para idade e sexo, houve diferença entre o grupo frágil no escore físico e no escore mental.
Conclusão: Dos oito domínios do SF-36, sete foram diferentes entre os grupos de fragilidade e, quando separados pelo
score físico e mental, o grupo frágil mostrou-se pior. Além disso, também houve correlação entre fragilidade e os
domínios de qualidade de vida, com exceção aos aspectos sociais. Intervenções sobre os componentes da fragilidade são
necessários para melhor conduzir o tratamento dos pacientes e melhorar sua qualidade de vida.
Palavras-chave: Fragilidade, Idosos, Qualidade de vida, Doença Renal crônicaIntroduction
Frailty is emerging as a common syndrome among older
adults. However, for patients with chronic kidney disease
(CKD), frailty has also been observed in younger age groups
[1,2]. This observation reflects a decline in physical func-
tioning and an increase in patient vulnerability [3]. Frailty
may even indicate an increased risk of adverse health effects
such as morbidity and mortality [4], further reducing pa-
tients’ quality of life (QOL).
Furthermore, frailty may lead to a worsening of the pa-
tient’s QOL, possibly due to a reduction in functional
capacity, which increases physical fatigue. Both of these
issues reduce the patient’s mobility, thus lowering social
interaction and generating dependency, which can be ag-
gravated in people with clinical complications such as
those related to CKD.
Some studies have shown that older adults who do not
suffer from CKD but exhibit characteristics of frailty (i.
e., exhaustion and reduced strength), show evidence of
reduced QOL and increased rates of depression [5-8].
Kanauchi et al. [5] assessed the relationship between
frailty, QOL, and wellbeing in older people with cardio-
metabolic risk factors. Lúpon et al. [6] observed frailty
and depressive symptoms in patients with heart failure.
Bilotta et al. [9] assessed the relationship between frailty
and QOL dimensions in an older Italian population andfound reduced QOL in frail participants, as did Lin et al.
[10] when studying an older Thai population.
However, to our knowledge, previous studies have not
explicitly examined relationships between frailty, QOL,
and depression in CKD patients. Because frailty is exac-
erbated and QOL reduced during the progression of
CKD [3,11,12], immediate diagnosis of both is necessary
for the implementation of therapeutic interventions de-
signed to minimize further complications.
Thus, the goal of the current study was to evaluate the




The Research Ethics Committee of the Federal University
of Juiz de Fora approved the current study. All patients pro-
vided written informed consent for participation in this
study. The sample comprised male and female adults (N =
61) receiving pre-dialysis treatment for Stages 3–5 CKD.
Patients were excluded if they presented with clinical condi-
tions diagnosed by a physician that would impede phys-
ical assessment (e.g., severe neurological pathologies,
gout, amputations, Parkinson’s disease, chronic obstructive
pulmonary disease, neoplasms, human immunodeficiency
virus, and severe physical sequelae caused by stroke or deep
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they exhibited significant cognitive decline, measured using
a translated and adapted version [13] of the Mini-Mental
State Examination [14].
Evaluation of kidney function and comorbidities
The diagnosis of CKD and disease stage was established by
estimating patients’ glomerular filtration rate (GFR), based
on serum creatinine (Cr) dosage, using a formula developed
for the MDRD study proposed by the National Kidney
Foundation [15]. Diagnosis was also confirmed through
documentation of renal parenchymal injury (i.e., proteinuria
and/or abnormal glomerular hematuria) existing for a
period exceeding three months.
Frailty
Frailty was evaluated via indicators of muscle weakness (a
Short Form-36 Health Survey (SF-36) physical function
score ≥ 75 points), exhaustion (an SF-36 vitality score ≥ 55
points), physical inactivity (whether a patient responded
“never” or “almost never” to a question about the frequency
of physical activity), and/or unintentional weight loss of
over 5 kg in the preceding year [1].
The muscle weakness criterion was worth 2 points,
while the others were worth 1 point. A patient with a
summed score between 0 and 2 points was categorized
as non-frail (NF) while a patient with a score of ≥3
points was categorized as frail (F).
Quality of life
The SF-36 is a shortened version of a questionnaire used in
the Medical Outcomes Study. It has been translated and
validated for Portuguese respondents in order to assess
QOL in this population [16]. The following QOL domains
were evaluated: Physical Functioning, Role Physical, Bodily
Pain, General Health, Vitality, Social Functioning, Role
Emotional, and Mental Health. While the SF-36 has no
cut-off point, scores that vary from 0 to 100 are assigned to
each domain. Lower scores indicate poorer QOL [17].
Using the Ware Algorithm [18], we transformed the
eight domains into two composite domains: a physical
component domain (comprising functional capacity, in-
dices of physical functioning, pain, general health, and
vitality) and a mental component domain (comprising
indices of social functioning, emotional functioning,
mental health, general health, and vitality).
Statistical analyses
We used SPSS version 17.0 (SPSS Inc., Chicago, Illinois)
or STATA version 11.0 (StataCorp LP, College Station,
Texas) for all analyses.
Patient characteristics, including demographic, clinical,
and laboratory characteristics, were presented as means ±
SD or frequencies (i.e., percentage of the total). All variablesmet the assumptions of normality as indicated by the
Kolmogorov-Smirnov test. Comparisons between the two
groups were performed using independent-sample t-tests.
Chi-square tests were performed in order to identify cat-
egorical variables associated with frailty, and Spearman’s
correlation analysis was used to measure associations be-
tween identified variables and frailty.
To evaluate differences in standardized SF-36 scores
between frailty groups, we used a multiple regression
model with frailty variables. The NF condition was used
as a reference. The model controlled for gender and age.
Results were expressed as adjusted means, and differ-
ences were assessed between these for patients catego-
rized as NF. The significance threshold was 0.05.
Results
The mean age of the sample was 60.5 ± 11.5 years, and
42.6% of the participants were diagnosed as frail. Table 1
shows the demographic, clinical, and laboratory data for pa-
tients, divided into F and NF groups. The groups differed
significantly in terms of age (p = 0.009), gender (p = 0.02),
and all QOL domains (Physical Functioning: p = 0.0001;
Role Physical: p = 0.03; Bodily Pain: p = 0.03; General
Health: p = 0.04; Vitality: p = 0.002; Mental Health: p = 0.05)
except Social Functioning and Role Emotional. However,
they did not differ in race, body mass index (BMI), smoking
status, CKD stage, CKD etiology, comorbidities, Cr level, or
GFR.
Table 2 shows the association between frailty and demo-
graphic, laboratory, and QOL variables. Frailty did not cor-
relate with Cr or GFR but correlated significantly with all
QOL domains (Physical Functioning: r = -0.82, p = 0.0001;
Role Physical: r = -0.41, p = 0.001; Bodily Pain: r = -0.28, p =
0.03; General Health: r = -0.31, p = 0.001; Vitality: r = -0.57,
p = 0.0001; Mental Health: r = -0.36, p = 0.05) except Social
Functioning and Role Emotional.
QOL represents multiple factors related to patients’
perception of their own lives. In an effort to understand
which domains were most strongly associated to frailty,
we assessed differences between the F and NF groups
based on the composite physical and mental SF-36
domains.
As indicated in Table 3 and Figure 1, simple linear regres-
sion adjusted for age and gender revealed a significant dif-
ference between groups for the physical (cof = -1.12 [-1.47
to -0.76], p = 0.001) and mental (cof = -0.75 [-1.4 to -0.16],
p = 0.02) SF-36 components.
Discussion
The purpose of the current study was to verify the rela-
tionship between QOL and frailty in pre-dialysis CKD
patients. The prevalence of frailty in the current sample
(42.6%) fell between that documented in other samples
(67.7% and 20.9%, [1,3]). It should be noted, however,
Table 1 Details of demographic and clinical data, as well as biochemical parameters, of the total sample (n = 61) and
separated by frailty classification in a group of Brazilian patients with pre-dialysis chronic kidney disease
Total (n = 61) Non-frail (n = 35) Frail (n = 26) p
Mean ± SD or n (%)
Age (years) 60.5 ± 11.5 57.3 ± 11.4 64.9 ± 10.3 0.009*
Female 25 (41.0%) 10 (28.6%) 15 (57.7%) 0.02*
Black phenotype 28 (45.9%) 13 (37.1%) 11 (42.3%) 0.11
Body mass index (kg/m 2) 25.9 ± 5.0 26.2 ± 4.0 28.0 ± 5.5 0.16
Smoking status 9 (14.8%) 5 (14.3%) 4 (15.4%) 0.90
Chronic kidney disease stages 0.15
3 24 (39.3%) 17 (48.6%) 7 (26.9%)
4 25 (42.6%) 12 (34.3%) 13 (50.0%)
5 12 (19.7%) 6 (17.1%) 6 (23.1%)
Etiology of chronic kidney disease 0.56
Arterial hypertension 18 (29.5%) 11 (31.4%) 7 (26.9%)
Diabetes mellitus 11 (18.0%) 4 (11.4%) 7 (26.9%)
Glomerulonephritis 9 (14.8%) 7 (20.0%) 2 (7.7%)
Unknown 8 (13.1%) 4 (11.4%) 4 (15.4%)
Undetermined or other 15 (24.6%) 9 (25.7%) 6 (23.1%)
Comorbidities 0.10
Arterial hypertension 23 (56.1%) 14 (40.0%) 9 (34.6%)
Diabetes mellitus 4 (9.8%) 3 (8.6%) 1 (2.6%)
Other 25 (41.0%) 11 (31.5%) 14 (53.9%)
None 9 (22.0%) 7 (20.0%) 2 (7.7%)
Creatinine (mg/dL) 2.7 ± 1.3 2.7 ± 1.5 2.7 ± 1.0 0.89
Glomerular filtration rate (mL/min/ 1.73 m 2) 26.8 ± 12.9 28.6 ± 13.1 24.3 ± 12.5 0.19
SF-36 domains
Physical functioning 67.2 ± 25.3 84 ± 15.3 46 ± 19 0.0001*
Role physical 65.9 ± 38.7 75 ± 35.3 53.8 ± 40.4 0.03*
Bodily pain 68.8 ± 31.7 76.5 ± 26.7 58.4 ± 35.3 0.03*
General health 56.4 ± 25.2 62 ± 23.8 48.9 ± 25.6 0.04*
Vitality 69.5 ± 23.3 77.4 ± 21.6 58.8 ± 21.5 0.002*
Social functioning 85.4 ± 25.7 84.9 ± 28.4 86 ± 22.1 0.87
Role emotional 74.5 ± 37.2 76.1 ± 36.7 72.3 ± 38.5 0.69
Mental health 76.0 ± 22.3 80.8 ± 21.3 69.5 ± 22.5 0.05*
*p < 0.05.
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studies differed from those used in the current study.
As in this study, others have associated frailty with dimin-
ished QOL in older adults with various pathologies. These
results are similar despite differences in the instruments
used to evaluate QOL and frailty.
Kanauchi et al. [5] evaluated 101 older patients with
cardiometabolic risk factors and concluded that frail
patients had decreased QOL as assessed by the Vulner-
ability Elderly Survey Index (VESI) and all domains of
the World Health Organization QOL (WHOQOL)
assessment.In a cross-sectional study, Bilotta et al. [9] examined older
Italian participants from the Study of Osteoporotic Frac-
tures (SOF), which correlated frailty with QOL life domains
from the Older People Quality of Life (OPQOL) instru-
ment. Similar to the results in our study, there was no rela-
tionship between frailty and QOL domains except social
relationships and financial circumstances.
Using the SF-36, Lin et al. [10] analyzed the relationship
between frailty through a phenotype proposed by Fried
et al. [7] and QOL domains in 933 older participants in
Taiwan. The results demonstrated that frailty was associ-
ated with all domains except for the physical, emotional,
Table 2 Correlation between frailty criteria and age,
creatinine, glomerular filtration rate, and quality of life





Glomerular filtration rate -0.15 0.24
Functional capacity -0.82 0.0001*
Physical aspects -0.41 0.001*
Pain -0.28 0.03*
General state of health -0.31 0.001*
Vitality -0.57 0.0001*
Social aspects -0.12 0.36
Emotional aspects -0.19 0.14
Mental health - 0.36 0.005*
*p < 0.05.
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that were not significantly associated with frailty were the
emotional and social domains; however, there was a rela-
tionship between frailty and the physical and mental com-
posite domains.
The relationship between frailty and depression is also
relevant. This relationship will be clarified in prospective
studies that plan to verify the associations between
QOL, depression, frailty, and negative outcomes (e.g.,
hospitalization and mortality).
Lúpon et al. [6] evaluated the relationship between
frailty and depression in 622 hospitalized patients with
heart failure who died one year post-assessment. Frailty
and depression were associated with worse outcomes.
However, only frailty held prognostic value for mortality,
even after adjusting for confounds in the multivariate ana-
lyses. In their study, the QOL measure—the Minnesota
Living with Heart Failure Questionnaire—was not associ-
ated with either frailty or depression.
In another analysis, Masel et al. [8] evaluated the relation-
ship between frailty, QOL, and mortality in 1,008 older
Mexicans over periods of two and three years. QOL was
assessed using the SF-36. Frailty was associated with mor-
tality during the study period; however, this association wasTable 3 Differences between frailty groups on composite SF-3




Frail -1.81 -0.75 (-1.4; -0.16) 0.02
*Averages adjusted for gender and age in years.attenuated following adjustment of the SF-36 physical
domain.
A relationship between QOL and depression in CKD
patients has been observed [19-23]. However, previous
studies have not assessed the association between frailty
and QOL in this patient population.
Regarding the relationship between frailty and QOL,
we argue that frailty directly influences QOL by reducing
patients’ physical and functional capacity. This, in turn,
exacerbates symptoms related to the mental domain.
In CKD, the relationship between frailty and QOL is
due to specific factors, including weakness, fatigue,
weight loss, low levels of physical activity, social exclu-
sion, mild cognitive changes, and increased vulnerability
to stressors [7].
We evaluated depression within a sub-sample of pa-
tients in our study (n = 37) using the Beck Depression
Inventory (BDI). We did not find a relationship between
frailty and depression (data not shown).
However, some studies, such as the Netherlands Co-
operative Study on the Adequacy of Dialysis (NECO-
SAD) project conducted by Van Den Beukel et al. [24],
have assessed depression by using the mental health and
emotional domains or the mental composite score.
When the mental health domain was used as an indica-
tor of negative mood, our data confirmed an association
between frailty and depression. Chang et al. [25], when
evaluating 1,240 patients from the Women’s Health and
Aging Studies (WHAS) I and II, recently revealed a simi-
lar result.
We also found a difference between frailty groups with
respect to age and gender, with the frail group compris-
ing patients who were older and predominantly female.
This is similar to the majority of studies that have
assessed frailty.
Fried et al. [7] found that age was a contributing factor
to the frailty of 5,317 older patients without CKD from
the Cardiovascular Health Study (CHS). Women, regard-
less of age, were more frail then men. Shilipak et al. [26]
compared 5,808 older patients with and without CKD
and found a higher prevalence of frailty among black
women, regardless of CKD status.
In another large study assessing frailty in CKD pa-




0.6 -1.12 (-1.47; -0.76) < 0.001
Figure 1 Box plot showing the difference between the non frailty and frailty groups on physical and mental component scores.
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lysis and was associated with gender (i.e., women were
55% more likely than men to be frail). In addition, this
study demonstrated that age was not a reliable predictor
of frailty since it was also observed in a significant por-
tion of younger adults.
The current study has some notable limitations. First,
we utilized a cross-sectional design, which was restricted
to assessing whether there were associations between
frailty, QOL, and depression (i.e., no causal inferences
can be made). Second, our study employed a small sam-
ple recruited from a single treatment center.
We can better manage patient health by exploring the
QOL domains that are affected by frailty. Thus, several
strategies should be implemented to improve QOL, in-
cluding physical exercise, treatment of anemia, maintain-
ing hormonal balance, stress management, reduction of
inflammation, and treatment for depression.
Additional longitudinal studies evaluating frailty, depres-
sion, and QOL among patients with CKD, particularly
those undergoing pre-dialysis treatment, are required to
clarify these relationships further.
Conclusion
The data presented in the current study allowed us to
conclude that of the eight SF-36 domains, seven were
significantly different between frail and non-frail CKD
patients. When separated according to physical and
mental scores, frail patients performed more poorly. In
addition, there were correlations between frailty and
QOL domains, excluding indices of social functioning.
Therapeutic interventions applied to the components of
frailty are needed in order to implement better patient
care and improve QOL.Competing interests
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